7Baggers
Quarterly
Annual
    Unit: USD2025-09-30 2025-06-30 2025-03-31 2024-12-31 2024-09-30 2024-06-30 2024-03-31 2023-12-31 2023-09-30 2023-06-30 2020-12-31 2020-09-30 2020-06-30 2020-03-31 2019-12-31 2019-09-30 2019-06-30 2019-03-31 2018-12-31 2018-09-30 2018-06-30 2018-03-31 2017-12-31 2017-09-30 2017-06-30 2017-03-31 2016-12-31 2016-09-30 2016-06-30 2015-12-31 2014-12-31 2014-12-31 2014-09-17 2014-06-30 2013-09-17 2013-09-17 2012-09-17 2012-09-17 
      
                                          
      revenue
                                          
      product revenue
    67,455,000 59,952,000 49,324,000 73,694,000 58,555,000 31,106,000 715,000 482,000 469,000 238,000                             
      total revenue
    67,455,000 59,952,000 49,324,000 73,694,000 58,555,000 31,106,000 715,000 176,750 469,000 238,000                             
      ​
    11,900                                      
      costs and expenses *
                                          
      cost of sales **
    38,477,000                                      
      research and development **
    75,174,000                                      
      selling, general, and administrative **
    34,555,000                                      
      depreciation and amortization
    9,007,000                                      
      restructuring charges
    5,143,000                                      
      total costs and expenses
    162,356,000 173,726,000 170,545,000 160,270,000 147,621,000 133,020,000 118,437,000 121,738,000 118,830,000 110,324,000 68,534,000 58,966,000 63,627,000 70,810,000 65,110,000 51,611,000 50,165,000 39,986,000 34,943,000 35,060,000 31,378,000 26,877,000 26,071,000 22,343,000 23,581,000 20,882,000 15,922,000 18,979,000 11,727,000    55,141,399 2,110,169 31,975,292 31,975,292 25,244,352 25,244,352 
      income from operations
    -94,901,000 -113,774,000 -121,221,000 -86,576,000 -89,066,000 -101,914,000 -117,722,000 -121,256,000 -118,361,000 -110,086,000 -68,534,000 -58,966,000 -63,627,000 -70,810,000 -65,110,000 -51,611,000 -50,165,000 -39,986,000 -34,943,000 -35,060,000 -31,378,000 -26,877,000 -26,071,000 -22,343,000 -23,581,000 -20,882,000 -15,922,000 -18,979,000 -11,727,000    -55,141,399 -2,110,169 -31,975,292 -31,975,292 -25,244,352 -25,244,352 
      yoy
    6.55% 11.64% 2.97% -28.60% -24.75% -7.42% 71.77% 105.64% 86.02% 55.47% 5.26% 14.25% 26.84% 77.09% 86.33% 47.21% 59.87% 48.77% 34.03% 56.92% 33.06% 28.71% 63.74% 17.72% 101.08%    -78.73%    118.43% -91.64%     
      qoq
    -16.59% -6.14% 40.02% -2.80% -12.61% -13.43% -2.91% 2.45% 7.52% 60.63% 16.23% -7.33% -10.14% 8.75% 26.16% 2.88% 25.46% 14.43% -0.33% 11.73% 16.75% 3.09% 16.69% -5.25% 12.93% 31.15% -16.11% 61.84%     2513.13% -93.40% 26.66% 26.66%   
      operating margin %
                                          
      other income
                                          
      interest and other income
    1,243,000 4,104,000 3,220,000                                0.00% 0.00% 0.00% 0.00% 
      net income before income taxes
    -93,658,000 -109,670,000 -118,001,000 -77,001,000 -85,061,000 -98,559,000 -114,384,000 -118,138,000 -115,003,000 -107,005,000                             
      income tax benefit
    2,405,000 -1,988,000 1,838,000 -1,558,000 1,520,000 1,458,000 1,408,000 1,759,000 1,243,000 477,000                             
      net income
    -91,253,000 -111,658,000 -116,163,000 -78,559,000 -83,541,000 -97,101,000 -112,976,000 -116,379,000 -113,760,000 -106,528,000 -68,397,000 -58,571,000 -63,018,000 -69,595,000 -63,568,000 -49,487,000 -47,551,000 -36,950,000 -32,575,000 -33,830,000 -30,660,000 -26,515,000 -25,854,000 -22,149,000 -23,377,000 -20,684,000 -15,688,000 -18,758,000 -11,563,000    -58,325,072 -2,110,169     
      yoy
    9.23% 14.99% 2.82% -32.50% -26.56% -8.85% 65.18% 98.70% 80.52% 53.07% 7.60% 18.36% 32.53% 88.35% 95.14% 46.28% 55.09% 39.36% 26.00% 52.74% 31.15% 28.19% 64.80% 18.08% 102.17%    -80.17%    75.95% -93.63%     
      qoq
    -18.27% -3.88% 47.87% -5.96% -13.96% -14.05% -2.92% 2.30% 6.79% 55.75% 16.78% -7.06% -9.45% 9.48% 28.45% 4.07% 28.69% 13.43% -3.71% 10.34% 15.63% 2.56% 16.73% -5.25% 13.02% 31.85% -16.37% 62.22%     2664.00% -94.00% 6.07% 6.07%   
      net income margin %
                                          
      net income per share
    -0.25 -0.33 -0.36 -0.25 -0.28 -0.34 -0.42 -0.45 -0.46 -0.47 -0.47 -0.4 -0.47                -0.23     -0.09     
      weighted-average shares of common stock outstanding, basic and diluted
    364,037 334,511 322,868 289,877 303,269 284,817 266,220 235,131 245,817 224,481 138,301 146,492 133,162                          
      * non-cash stock-based compensation included in cost of sales and operating expenses
                                      -35,159,979 -35,159,979 -33,149,255 -33,149,255 
      cost of sales
    1,408 56,664,000 49,741,000 45,543,000 39,823,000 31,368,000 7,261,000 4,365,000 4,340,000 2,050,000                             
      gross profit
                                      0.00% 0.00% 0.00% 0.00% 
      yoy
                                          
      qoq
                                          
      gross margin %
                                          
      research and development
    5,011 79,363,000 76,879,000 72,224,000 68,245,000 62,084,000 79,783,000 87,470,000 87,526,000 86,347,000             17,586,000 17,753,000 19,653,000 16,623,000 10,837,000 8,481,000 4,463,000    5,215,074 361,227     
      selling, general and administrative
    5,481   27,628,500 39,553,000 39,568,000 31,393,000 29,903,000 26,964,000 21,927,000                             
      ** excludes depreciation and amortization
                                          
      costs and expenses
                                          
      selling, general, and administrative
     37,699,000 43,925,000                                    
      interest income
       2,674,500 4,005,000 3,355,000 3,338,000 3,118,000 3,358,000 3,081,000 137,000 395,000 609,000 1,215,000 1,542,000 2,124,000 2,614,000 3,036,000 2,368,000 1,230,000 718,000 362,000 217,000 194,000 204,000 198,000 234,000 221,000 164,000          
      revenues
                                          
      research and development expenses
              52,451,000 43,050,000 49,274,000 56,952,000 54,238,000 41,582,000 39,298,000 30,905,000 27,418,000 27,947,000 24,551,000 19,912,000                 
      general and administrative expenses
              16,083,000 15,916,000 14,353,000 13,858,000 10,872,000 10,029,000 10,867,000 9,081,000 7,525,000 7,113,000 6,827,000 6,965,000                 
      net income per common share, basic and diluted
                 -550 -510 -400 -380 -300 -260 -360 -340 -310 -350 -350 -370 -330 -210 -1,150           
      weighted- average common shares outstanding, basic and diluted
                 126,568,000                     4,103,045 4,103,045 2,813,045 2,813,045 
      weighted-average common shares outstanding, basic and diluted
                   124,035,000 123,567,000 123,415,000  95,077,000 90,236,000 84,350,000 65,242,000 63,332,000 62,457,000 62,286,000 55,268,000 59,113,000 51,081,519 44,410,036         
      general and administrative
                          8,485,000 4,590,000 3,928,000 4,259,000 5,085,000 10,498,000 7,264,000          
      deemed dividend related to beneficial conversion feature of convertible preferred stock
                               -49,454,000     -8,461,627      
      net income attributable to common stockholders
                          -25,854,000 -22,149,000   -15,688,000 -68,212,000     -66,786,699      
      32.2
                                          
      101.ins
                                          
      101.sch
                                          
      101.cal
                                          
      101.def
                                          
      101.lab
                                          
      101.pre
                                          
      november 13, 2014
                                          
      operating expenses
                                    33,110,039 1,748,942     
      cost of lion transaction - related party
                                    16,656,250      
      impairment of intangible asset
                                    160,036      
      interest expense
                                    -2,517,945      
      change in fair value of derivative liabilities
                                    10,001,955      
      amortization of discount on convertible notes
                                    -5,497,888      
      cost to induce exchange transaction
                                    -2,295,868      
      financing costs
                                    -2,873,927      
      total other income
                                    -3,183,673      
      weighted-average common shares
                                          
      outstanding, basic and diluted
                                     24,137,782 27,712,211 27,712,211   
      operating expenses (including 1,227,227
                                          
      40,302, and 15,835,268 of non-cash
                                      160,036 160,036 160,036 160,036 
      share-based compensation costs)
                                      -2,518,959 -2,518,959 -239,979 -239,979 
      private placement costs
                                      10,001,955 10,001,955 -1,181,266 -1,181,266 
    The information provided in this report is taken from www.sec.gov and many other data providers. While we have conducted our best efforts to ensure that the parsed data is accurate, we cannot guarantee its accuracy. Please use caution and understand that any consequences of its use are your own responsibility.